Brian Ennis Appointed President of Empi, Inc. and Compex Technologies, Inc., Subsidiaries of Encore Medical Corporation
07 Marzo 2006 - 10:33AM
PR Newswire (US)
AUSTIN, Texas, March 7 /PRNewswire-FirstCall/ -- Brian T. Ennis has
been appointed President of Encore Medical Corporation's
(NASDAQ:ENMC) subsidiaries, Empi, Inc. and the recently acquired
Compex Technologies, Inc., effective immediately, it was announced
today by Paul Chapman, President and Chief Operating Officer of
Encore Medical. In his new assignment, Mr. Ennis will be
responsible for leading the combination of the two companies and
building the Encore home orthopedic rehabilitation platform. The
acquisition of Compex was completed by Encore in late February and
a key initiative for Encore is bringing together these two
organizations in a manner that builds sales while achieving greater
operating income through exploiting synergies and operating
leverage. Mr. Ennis will be at the forefront of these efforts,
leading a combined workforce of approximately 1,100, which includes
the direct sales forces of each organization. Commenting on the
announcement, Mr. Chapman said, "A key element of Encore's ongoing
success will be our ability to bring together the Empi and Compex
organizations and grow our Orthopedic Rehabilitation Division
revenues, increase our margins, and build our profits. Under
Brian's able leadership, we are confident that he can harness the
efforts of all of the capable and hard working Compex and Empi
employees to build towards these goals." Mr. Ennis brings with him
significant experience in the orthopedic area, having worked at
Stryker Corporation from 1989 to 2000, in both their domestic and
international marketing and management areas, as well as most
recently holding the position of President of International at
Wright Medical Group from 2001 to 2005. In both of those companies,
he demonstrated an ability to grow revenues and build
organizations. Encore Medical Corporation is a diversified
orthopedic device company that develops, manufactures and
distributes a comprehensive range of high quality orthopedic
devices used by orthopedic surgeons, physicians, therapists,
athletic trainers and other healthcare professionals to treat
patients with musculoskeletal conditions resulting from
degenerative diseases, deformities, traumatic events and
sports-related injuries. Through its Orthopedic Rehabilitation
Division, Encore is a leading distributor of electrical stimulation
and other orthopedic products used for pain management, orthopedic
rehabilitation, physical therapy, fitness and sport performance
enhancement. Encore's Surgical Implant Division offers a
comprehensive suite of reconstructive joint products and spinal
implants. For more information, visit http://www.encoremed.com/ .
Contact Davis Henley, Vice President - Business Development (512)
832-9500 Except for the historical information contained herein,
the matters discussed are forward-looking statements made pursuant
to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. These statements involve risks and
uncertainties, such as fluctuations in operating results, the
timely availability of new products, the impacts of competitive
products and pricing, the effects of integration efforts, including
retaining customers and employees, the ability to grow and
integrate the distribution networks for the Company's products, the
ability to continue to obtain long- term financing, and the ability
to locate and integrate future acquisitions and other risks and
uncertainties set forth in the Company's filings with the
Securities and Exchange Commission. These risks and uncertainties
could cause actual results to differ materially from any
forward-looking statements made herein. DATASOURCE: Encore Medical
Corporation CONTACT: Davis Henley, Vice President - Business
Development of Encore Medical Corporation, +1-512-832-9500, or Web
site: http://www.encoremed.com/
Copyright
Encore Medical (NASDAQ:ENMC)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Encore Medical (NASDAQ:ENMC)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Encore Medical (NASDAQ): 0 recent articles
Más de Encore Medical (MM) Artículos de Noticias